2009
DOI: 10.1007/s11095-009-9910-6
|View full text |Cite
|
Sign up to set email alerts
|

Semi-Mechanistic Model for Neutropenia after High Dose of Chemotherapy in Breast Cancer Patients

Abstract: The time course of neutropenia following high-dose of chemotherapy and PBSC transplantation was accurately predicted. Higher amount of CD34+ cells in the PBSC transplantation and earlier administration rHuG-CSF were associated with faster haematological recovery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(23 citation statements)
references
References 53 publications
0
23
0
Order By: Relevance
“…Two patients in the 10-µg/kg cohort and 1 patient in the 0.2-µg/kg and in the 0.4-µg/kg cohorts received a single dose of romiplostim. Predose platelet counts were obtained on days -8 and -2 and on days 1, 3,5,8,10,12,15,17,19,22,24,26,29,32,36,43,50, and 64 postdose. Different patients were enrolled in parts A and B.…”
Section: Methods Study Designmentioning
confidence: 99%
See 1 more Smart Citation
“…Two patients in the 10-µg/kg cohort and 1 patient in the 0.2-µg/kg and in the 0.4-µg/kg cohorts received a single dose of romiplostim. Predose platelet counts were obtained on days -8 and -2 and on days 1, 3,5,8,10,12,15,17,19,22,24,26,29,32,36,43,50, and 64 postdose. Different patients were enrolled in parts A and B.…”
Section: Methods Study Designmentioning
confidence: 99%
“…Patients subsequently received 2 doses of 30, 100, 300, or 500 µg of romiplostim. Platelet counts were obtained at baseline on days -8 and -2 and on days 1, 3, 5, 8, 10,12,15,17,19,22,24,26,29,32,36,43,50,64, and 78 after romiplostim administration.…”
Section: Methods Study Designmentioning
confidence: 99%
“…Proposed alterations of the model structure include a log-linear drug effect model instead of a linear or Emax model [10], an addition of an effect delay compartment to account for the distribution of drug from the plasma to the bone marrow [10] and an addition of a neutrophil pool to describe an early increase of neutrophil count after dosage [20]. The model has further been extended to describe the combined drug effect following combination therapy of anticancer drugs [13,17,18,[21][22][23][24], to incorporate the effect of administrated exogenous G-CSF [22,25,26] and to capture the time-course of neutrophils following peripheral blood stem-cell transplantation [26]. Additionally covariates [6,9,10,20,[27][28][29][30] and inter-occasion variability [16] have been explored using the model.…”
Section: Introductionmentioning
confidence: 99%
“…The ANC dynamics component of the model was represented by a catenary chain of four compartments to mimic the production and maturation of neutrophils in the bone marrow . The receptors were tracked through the production, maturation and turnover of neutrophils, which were represented by stem cells ( R SM ), cells undergoing mitosis ( R MT ) and the two precursor states in the bone marrow ( R PM 1 and R PM 2 ).…”
Section: Methodsmentioning
confidence: 99%